Potenzial des Ultraschalls bei allogener Stammzelltransplantation und transplantationsassoziierten Komplikationen

Zusammenfassung

Die allogene hämatopoietische Stammzelltransplantation (allo-SZT) stellt eine komplexe Therapie mit vielen auch gastrointestinalen Nebenwirkungen und Komplikationen dar. Eine frühzeitige Diagnose und Behandlung von mit allo-SZT assoziierten Komplikationen ist daher von großer Bedeutung, um das Überleben dieser Patienten zu verbessern. Die Sonografie stellt eine schnell verfügbare Methode dar, die am Krankenbett durchgeführt werden kann. In den Händen eines sonografieerfahrenen Untersuchers können wichtige transplantationsbedingte Komplikationen sofort diagnostiziert oder ausgeschlossen werden. Das Ziel der Arbeit ist es, den diagnostischen und klinischen Wert von Ultraschall vor, während und nach der allo-SZT darzustellen.

Abstract

Allogeneic hematopoietic stem cell transplantation (HCT) is a complex therapeutic procedure causing significant morbidity and mortality, including the gastrointestinal tract. Early diagnosis and treatment of HCT-associated complications are, therefore, of utmost importance to improve overall HCT outcome. Sonography can be a powerful diagnostic tool and is easily accessible at the bedside of HCT patients. In the hands of a sonography-experienced physician, it allows for instant diagnosis and can also rule out several important transplant-associated complications. Here we review available evidence on the diagnostic and clinical value of ultrasound prior, during and after HCT.

Schlüsselwörter

GvHD - Guideline - allogene Stammzelltransplantation - Colitis - Splenomegalie - Komplikationen

Key words

GVHD - guideline - allogeneic stem cell transplantation - colitis - splenomegaly - complications

• Literatur

• 1 Beelen D, Bethge W. et al Leitlinien zur allogenen Stammzelltransplantation von der Deutschen Arbeitsgemeinschaft für Knochenmark- und Blutstammzelltransplantation (DAG-KBT): 8. Akute Komplikationen und supportive Maßnahmen (mit Ausnahme von Infektionen und GvHD) Version 1 2016. https://dag-kbt.de/files/downloads/Leitlinien_Kap-8_Akute%20Komplikationen%20und%20supp.%20Massnahmen.pdf (abgerufen am 09.09.2020).
• 2 Sienz M, Ignee A, Dietrich CF. [Reference values in abdominal ultrasound – biliopancreatic system and spleen]. Z Gastroenterol 2011; 49: 845-870
• 3 Sienz M, Ignee A, Dietrich CF. [Reference values in abdominal ultrasound – liver and liver vessels]. Z Gastroenterol. © Georg Thieme Verlag KG Stuttgart · New York 2010; 48: 1141-1152
• 4 Lassau N, Leclère J, Auperin A. et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology 1997; 204: 545-552
• 5 Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. John Wiley & Sons, Ltd (10.1111) 2007; 25: 1135-1151
• 6 Lee WM. Drug-induced hepatotoxicity. N Engl J Med. Massachusetts Medical Society 2003; 349: 474-485
• 7 Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society of Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Disease Society of America (IDSA). et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. 2009: 453-558
• 8 Carreras E, Dufour C, Mohty M. et al. The EBMT Handbook. Springer; 2018: 1
• 9 Gerber DE, Segal JB, Levy MY. et al. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood 2008; 112: 504-510
• 10 Pihusch R, Salat C, Schmidt E. et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 2002; 74: 1303-1309
• 11 Labrador J, Lopez-Anglada L, Perez-Lopez E. et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica 2013; 98: 437-443
• 12 Michels G, Jaspers N. Notfallsonografie. Michels G, Jaspers N. editors. Berlin, Heidelberg: Springer-Verlag; 2013: 1
• 13 Laursen CB, Sloth E, Lassen AT. et al. Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trial. Lancet Respir Med 2014; 2: 638-646
• 14 Osterwalder J, Mathis G, Hoffmann B. New Perspectives for Modern Trauma Management – Lessons Learned from 25 Years FAST and 15 Years E-FAST. Ultraschall in Med 2019; 40: 560-583
• 15 Sidhu PS, Cantisani V, Dietrich CF. et al The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall in Med. © Georg Thieme Verlag KG 2018; (EFirst).
• 16 Lv F, Tang J, Luo Y. et al. Contrast-enhanced ultrasound imaging of active bleeding associated with hepatic and splenic trauma. Radiol Med. Springer Milan 2011; 116: 1076-1082
• 17 Patel K, West HJ. Febrile Neutropenia. JAMA Oncol. American Medical Association 2017; 3: 1751-1751
• 18 Almyroudis NG, Fuller A, Jakubowski A. et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 4 ed. John Wiley & Sons, Ltd 2005; 7: 11-17
• 19 Collin BA, Leather HL, Wingard JR. et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947-953
• 20 Averbuch D, Orasch C, Cordonnier C. et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013; 1826-1835
• 21 Ninin E, Milpied N, Moreau P. et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41-47
• 22 Poutsiaka DD, Price LL, Ucuzian A. et al. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. Nature Publishing Group 2007; 40: 63-70
• 23 Freifeld AG, Bow EJ, Sepkowitz KA. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Vol. 52. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2011; 427-431
• 24 Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-1332
• 25 Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol 2017; 23: 42-47
• 26 Katz JA, Wagner ML, Gresik MV. et al. Typhlitis. An 18-year experience and postmortem review. Cancer. John Wiley & Sons, Ltd 1990; 65: 1041-1047
• 27 Wade DS, Nava HR, Douglass HO. Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 1992; 69: 17-23
• 28 Ullery BW, Pieracci FM, Rodney JRM. et al. Neutropenic enterocolitis. Surg Infect (Larchmt) 2009; 10: 307-314
• 29 Cartoni C, Dragoni F, Micozzi A. et al. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 2001; 19: 756-761
• 30 Leather HL, Wingard JR. Infections following hematopoietic stem cell transplantation. Infect Dis Clin North Am 2001; 15: 483-520
• 31 Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med. American Thoracic Society 2004; 170: 22-48
• 32 Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I. et al. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant. John Wiley & Sons, Ltd 2011; 25: E629-E638
• 33 Dettenkofer M, Wenzler-Röttele S, Babikir R. et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 2005; 40: 926-931
• 34 Ye X, Xiao H, Chen B. et al. Accuracy of Lung Ultrasonography versus Chest Radiography for the Diagnosis of Adult Community-Acquired Pneumonia: Review of the Literature and Meta-Analysis. Chalmers JD, editor. PLoS ONE. Public Library of Science 2015; 10: e0130066
• 35 Reissig A, Copetti R, Mathis G. et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012; 142: 965-972
• 36 Dietrich CF, Mathis G, Cui X-W. et al. Ultrasound of the pleurae and lungs. Ultrasound Med Biol 2015; 41: 351-365
• 37 Mathis G. Bildatlas der Lungen- und Pleurasonographie. Mathis G. editor Berlin, Heidelberg: Springer-Verlag; 2013: 1
• 38 Dietrich CF, Braden B, Wagner TOF. Thorax- und Lungensonografie. Dtsch Arztebl; A- B- C 2001; 98: A-103/B-88/C-88
• 39 Kelbel C, Börner N, Schadmand S. et al. [Diagnosis of pleural effusions and atelectases: sonography and radiology compared]. Rofo. © Georg Thieme Verlag Stuttgart · New York 1991; 154: 159-163
• 40 Xirouchaki N, Georgopoulos D. Impact of lung ultrasound on clinical decision making in critically ill patients: response to O'Connor et al.. Intensive Care Med 2014; 40: 1063-1063
• 41 Soni NJ, Franco R, Velez MI. et al. Ultrasound in the diagnosis and management of pleural effusions. J Hosp Med 2015; 10: 811-816
• 42 Wilhelm W. Praxis der Intensivmedizin. Wilhelm W. editor Berlin, Heidelberg: Springer-Verlag; 2011: 1
• 43 Thaler M, Pastakia B, Shawker TH. et al. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med. American College of Physicians 1988; 108: 88-100
• 44 Boulanger Y, Ghuysen M-S, Nchimi A. et al. Ultrasound Diagnosis and Follow-Up of Neonate Renal Candidiasis. J Belg Soc Radiol. Ubiquity Press 2016; 100: 113
• 45 Görg C, Bert T, Klassen E. et al. [Contrast enhanced sonographic patterns of hepatic candidiasis]. Z Gastroenterol 2010; 48: 678-682
• 46 Barker CC, Butzner JD, Anderson RA. et al. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant. Nature Publishing Group 2003; 32: 79-87
• 47 Cesaro S, Pillon M, Talenti E. et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396-1404
• 48 Corbacioglu S, Carreras E, Ansari M. et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant 2018; 53: 138-145
• 49 Dietrich CF, Trenker C, Fontanilla T. et al. New Ultrasound Techniques Challenge the Diagnosis of Sinusoidal Obstruction Syndrome. Ultrasound Med Biol 2018; 44: 2171-2182
• 50 Lassau N, Koscielny S, Avril M-F. et al. Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas. Am J Roentgenol. American Roentgen Ray Society 2002; 178: 1547-1551
• 51 Trenker C, Burchert A, Schumacher C. et al. Pathologic Hepatic Contrast-Enhanced Ultrasound Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation. Ultrasound Med Biol 2020; 46: 1865-1871
• 52 Trenker C, Sohlbach K, Dietrich CF. et al. Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound. Bone Marrow Transplant. Nature Publishing Group 2018; 48: 831
• 53 Lee S-E, Cho B-S, Kim J-H. et al. Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transplant. Nature Publishing Group 2013; 48: 587-592
• 54 Filipovich AH, Weisdorf D, Pavletic S. et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956
• 55 Jagasia M, Arora M, Flowers MED. et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119: 296-307
• 56 Zeiser R, Dreger P. et al Leitlinien zur allogenen Stammzelltransplantation von der Deutschen Arbeitsgemeinschaft für Knochenmark- und Blutstammzelltransplantation (DAG-KBT): 9. GvHD Prophylaxe und Therapie. https://www.dag-kbt.de/files/downloads/Leitlinien_Kap-09_GvHD-Prophylaxe%20und%20Therapie.pdf abgerufen am 13.09.2020
• 57 Ratanatharathorn V, Nash RA, Przepiorka D. et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998; 92: 2303-2314
• 58 Klein SA, Martin H, Schreiber Dietrich D. et al. A new approach to evaluating intestinal acute graft‐versus‐host disease by transabdominal sonography and colour Doppler imaging. British Journal of Haematology. Blackwell Science Ltd 2001; 115: 929-934
• 59 Klein SA, Hermann S, Dietrich JW. et al. Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies. Blood 2002; 99: 2270-2271
• 60 Görg C, Wollenberg B, Beyer J. et al. High-resolution ultrasonography in gastrointestinal graft-versus-host disease. Ann Hematol. Springer-Verlag 2005; 84: 33-39
• 61 Nishida M, Shigematsu A, Sato M. et al. Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation. Clin Transplant. John Wiley & Sons, Ltd 2015; 29: 697-704
• 62 Weber D, Weber M, Hippe K. et al. Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound. Bone Marrow Transplant 2019; 54: 1038-1048
• 63 Schreyer AG, Landfried K, Jung EM. et al. Contrast-enhanced ultrasound for differential diagnosis of suspected GvHD in patients after allogeneic transplantation. Clin Hemorheol Microcirc. IOS Press 2011; 49: 129-136
• 64 Schreyer AG, Landfried K, Zorger N. et al. Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplant. Nature Publishing Group 2011; 46: 1006-1011
• 65 Ajuk F, Bug G. et al Leitlinien zur allogenen Stammzelltransplantation von der Deutschen Arbeitsgemeinschaft für Knochenmark- und Blutstammzelltransplantation (DAG-KBT): 11 Langzeitnachsorge nach SZT. https://www.dag-kbt.de/files/downloads/Leitlinien_Kap-11_Langzeitnachsorge%20nach%20SZT.pdf (abgerufen am 15.09.2020)
• 66 Rocha V, Wagner JE, Sobocinski KA. et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. Massachusetts Medical Society 2000; 342: 1846-1854
• 67 Sullivan KM, Agura E, Anasetti C. et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259
• 68 Remberger M, Aschan J, Lönnqvist B. et al. An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation. European Journal of Haematology. John Wiley & Sons, Ltd 2001; 66: 50-56
• 69 Bhushan V, Collins RH. Chronic graft-vs-host disease. JAMA 290: 2599-2603
• 70 Zhang M, Mendiratta-Lala M, Maturen KE. et al. Quantitative Assessment of Liver Stiffness Using Ultrasound Shear Wave Elastography in Patients With Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Study. J Ultrasound Med 2019; 38: 455-461
• 71 Shimoni A, Shem-Tov N, Chetrit A. et al. Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced. Leukemia. Nature Publishing Group 2013; 27: 829-835
• 72 Cohen A, Rovelli A, Merlo DF. et al. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007; 25: 2449-2454
• 73 Majhail NS. Secondary cancers following allogeneic haematopoietic cell transplantation in adults. British Journal of Haematology. John Wiley & Sons, Ltd (10.1111) 2011; 154: 301-310
• 74 Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 4 ed. Springer US 2013; 8: 173-183
• 75 Trappe R, Oertel SP, Riess H. Pathogenese, Klinik, Diagnostik und Therapie transplantationsassoziierter lymphoproliferativer Erkrankungen. Deutsches Ärzteblatt 2006; 103: A-3259/B-2836/C-2718
• 76 Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381-394
• 77 Trappe RU, Dierickx D, Zimmermann H. et al. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial. J Clin Oncol. American Society of Clinical Oncology 2017; 35: 536-543
• 78 Zimmermann H, Trappe RU. et al EBV and posttransplantation lymphoproliferative disease: what to do?. Hematology Am Soc Hematol Educ Program 2013; 2013: 95-102 . doi:10.1182/asheducation-2013.1.95. PMID: 24319169
• 79 Bader P, Giudici L, Benden C. [CME: Lymphoproliferative diseases after transplantation (PTLD)]. Praxis (Bern 1994). Hogrefe AG 2016; 105: 123–8–quiz129–30
• 80 Nalesnik MA, Jaffe R, Starzl TE. et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. American Society for Investigative Pathology 1988; 133: 173-192
• 81 Trenker C, Kunsch S, Michl P. et al. Contrast-enhanced ultrasound (CEUS) in hepatic lymphoma: retrospective evaluation in 38 cases. Ultraschall in Med. © Georg Thieme Verlag KG 2014; 35: 142-148
• 82 Trenker C, Neesse A, Görg C. Sonographic patterns of renal lymphoma in B-mode imaging and in contrast-enhanced ultrasound (CEUS) – a retrospective evaluation. Eur J Radiol 2015; 84: 807-810
• 83 Görg C, Faoro C, Bert T. et al. Contrast enhanced ultrasound of splenic lymphoma involvement. Eur J Radiol 2011; 80: 169-174
• 84 Goerg C, Schwerk WB. Ultrasound of extranodal abdominal lymphoma – a review. Clin Radiol 1991; 44: 92-97
• 85 Dietrich CF, Hollerweger A, Dirks K. et al. EFSUMB Gastrointestinal Ultrasound (GIUS) Task Force Group: Celiac sprue and other rare gastrointestinal diseases ultrasound features. Vol. 21. Medical ultrasonography 2019; 299-315
• 86 Dietrich C, Lembcke B, Jenssen C. et al. Intestinal Ultrasound in Rare Gastrointestinal Diseases, Update, Part 1. Ultraschall in Med 2014; 35: 400-421
• 87 Dietrich C, Lembcke B, Jenssen C. et al. Intestinal Ultrasound in Rare Gastrointestinal Diseases, Update, Part 2. Ultraschall in Med 2015; 36: 428-456
• 88 Trenker C, Wilhelm C, Neesse A. et al. Contrast-Enhanced Ultrasound in Pulmonary Lymphoma: A Small Pilot Study. J Ultrasound Med. Wiley-Blackwell 2018; 44: 129